Scarica l'app Stockscreener
0.7767
10.33%
0.0727
Invivyd Inc Borsa (IVVD) Ultime notizie
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates - MSN
Invivyd (IVVD) Maintains Buy Rating with Stable Price Target | I - GuruFocus
Invivyd, Inc. (NASDAQ:IVVD) Q1 2025 Earnings Call Transcript - Insider Monkey
Invivyd Q1 2025 slides: Revenue grows amid regulatory hurdles and cash concerns - Investing.com Nigeria
Earnings call transcript: Invivyd Q1 2025 sees stock drop amid earnings miss - Investing.com Canada
Earnings call transcript: Invivyd Q1 2025 sees stock drop amid earnings miss By Investing.com - Investing.com South Africa
Invivyd Reports Q1 2025 Financial Results and Outlook - TipRanks
Invivyd’s Earnings Call: Strategic Moves Amid Challenges - TipRanks
INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc.IVVD, A - Barchart.com
Transcript : Invivyd, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Invivyd (IVVD) Reports Q1 Revenue Below Expectations Amid Strate - GuruFocus
Invivyd Reports Q1 2025 Financial Results and Highlights - TipRanks
INVIVYD Earnings Results: $IVVD Reports Quarterly Earnings - Nasdaq
Invivyd, Inc. SEC 10-Q Report - TradingView
Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Invivyd, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Invivyd calls for modernized FDA vaccine guidelines By Investing.com - Investing.com South Africa
Invivyd Launches New Measles Antibody Discovery Program: Retail Traders Bet On ‘Future Of Medicine’ - MSN
What To Expect From Invivyd Inc (IVVD) Q1 2025 Earnings - Yahoo Finance
Invivyd (IVVD) Urges FDA to Revise COVID-19 Vaccine Development - GuruFocus
Invivyd Urges US FDA to Focus on Monoclonal Antibodies for COVID-19 Prevention, Re-Assess Vaccine Efficacy - marketscreener.com
Invivyd calls for modernized FDA vaccine guidelines - Investing.com Australia
Invivyd Files Citizen Petition Urging FDA to Focus on Monoclonal Antibodies For Endemic-Virus-Era COVID-19 Prevention, and to Re-Assess COVID-19 Vaccine Efficacy - The Manila Times
Invivyd Urges FDA to Revolutionize COVID-19 Prevention: Calls for Major Shift from Vaccines to Antibody Treatments - Stock Titan
INVIVYD Earnings Preview: Recent $IVVD Insider Trading, Hedge Fund Activity, and More - Nasdaq
Invivyd initiates measles monoclonal antibody discovery program - BioWorld MedTech
What Does Invivyd Inc’s (NASDAQ: IVVD) Future Hold? - Stocksregister
Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - Yahoo Finance
Invivyd (IVVD) Advances Measles Monoclonal Antibody Program | IV - GuruFocus
Invivyd Launches New Measles Antibody Discovery Program: Retail Traders Bet On ‘Future Of Medicine’ By Stocktwits - Investing.com India
Invivyd begins discovery of measles monoclonal antibody By Investing.com - Investing.com South Africa
Invivyd Launches Program for Measles Antibody Treatment - TipRanks
Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles - The Manila Times
Invivyd begins discovery of measles monoclonal antibody - Investing.com
Invivyd Announces New Pipeline Discovery Program - marketscreener.com
INVIVYD SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc.IVVD, ADGI - Barchart.com
Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025 - The Manila Times
Invivyd, Inc. to Host Conference Call on May 15, 2025, to Discuss Q1 Financial Results and Business Highlights - Nasdaq
Senior Manager, Marketing Operations Waltham/Bostonwill consider remote at Invivyd, Inc. - Mediabistro
Invivyd Inc (NASDAQ: IVVD): Should Value Hunters Buy It? - Stocksregister
Geode Capital Management LLC Has $708,000 Position in Invivyd, Inc. (NASDAQ:IVVD) - The AM Reporter
Invivyd Inc (IVVD) expanding its growth trajectory ahead - Sete News
Guggenheim Upgrades Invivyd Inc (IVVD) to a Buy from a Neutral - knoxdaily.com
Market Recap Check: Invivyd Inc (IVVD)’s Negative Finish at 0.64, Up/Down -3.97 - DWinneX
Will Invivyd Inc (IVVD) meet earnings estimates this quarter? - uspostnews.com
What is Invivyd Inc (IVVD) Stock Return on Shareholders’ Capital? - Sete News
Guggenheim upgrades Invivyd Inc (IVVD) rating to a Buy - knoxdaily.com
Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms - Endpoints News
IVVD Stock Price and Chart — NASDAQ:IVVD - TradingView
Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Ba - GuruFocus
Invivyd Inc (IVVD) Stock: A Comprehensive 52-Week Review - investchronicle.com
Invivyd secures $30 million loan for COVID-19 antibody development By Investing.com - Investing.com South Africa
What's Going On With Invivyd Stock On Monday? - AOL.com
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):